Business
Ekso Bionics Reports First Quarter 2025 Financial Results
SAN RAFAEL, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2025. Recent Highlights and Accomplishments Strengthened financial position by improving operating cash burn by 43% combined with $3.8 million in net proceeds from the exercise of warrantsNamed National Seating & Mobility
About this update from Ekso Bionics Holdings, Inc.
[{"type":"image","alt":"Ekso Bionics Holdings, Inc.","displaySize":"","headline":null,"caption":"Ekso Bionics Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":53,"url":"https://media.zenfs.com/en/globenewswire.com/b411d746d7b7c3c2c7b1d711ecb53bf3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.8zV7BA7lcdq3vo2VGDYMw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b411d746d7b7c3c2c7b1d711ecb53bf3","width":300,"height":53}},"lazy":false},{"type":"text","content":"SAN RAFAEL, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2025.","length":283,"tagName":"p"},{"type":"text","content":"Recent Highlights and Accomplishments","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Strengthened financial position by improving operating cash burn by 43% combined with $3.8 million in net proceeds from the exercise of warrants","length":144,"tagName":"p"}]},{"val":[{"type":"text","content":"Named National Seating & Mobility (“NSM”) as its exclusive Ekso Indego® Personal device distributor within the U.S. complex rehabilitation technology (“CRT”) industry","length":170,"tagName":"p"}]},{"val":[{"type":"text","content":"Named Bionic Prosthetics & Orthotics Group (“Bionic P&O”) as its first Ekso Indego® Personal device distributor within the orthotics and prosthetics industry","length":165,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":479,"olType":false},{"type":"text","content":"“Over the past few weeks, we have significantly expanded access to Ekso Indego Personal via potentially transformative partnerships with two key leaders within their respective industries,” said Scott Davis, the Company’s Chief Executive Officer. “NSM, which operates in the CRT industry, brings a network of over 180 locations and more than 2,400 team members, who support more than 250,000 mobility solutions each year. While Bionic P&O, a leading national provider of prosthetic and orthotic solutions, is an ABC accredited independent clinical practice group that now operates across 12 states. Both partnerships represen...